Objective This study evaluated the characteristics of new users of sodium glucose co-transporter 2 inhibitors (SGLT2i) in clinical practice to assess the applicability of the findings from clinical trials (Empagliflozin. Cardiovascular Outcomes and Mortality in Type 2 Diabetes (EMPA-REG OUTCOME) trial. Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 trial. Canagliflozi... https://mysocialfeeder.com/story4381217/red%C3%A9finition-des-r%C3%A9cits-urbains-analyse-de-deux-d%C3%A9placements-du-centre-politique-de-macap%C3%A1-1944-et-1967